Table 1.
Baseline characteristics of donors who underwent a major living donor hepatectomy between April 2012 and July 2021
| Variable | Patients no. (%) | P value | |
|---|---|---|---|
| Textbook outcome ( −) | Textbook outcome ( +) | ||
| Total | 308 (30.1) | 714 (69.9) | NA |
| Sex | 0.393 | ||
| Male | 203 (29.3) | 490 (70.7) | |
| Female | 165 (31.9) | 164 (68.1) | |
| Age, years, median (IQR) | 26 (21.2–34) | 25 (25–32) | 0.942 |
| Body mass index, median (IQR), Kg/m2 | 24.3 (21.9–26.8) | 24 (21.1–26.9) | 0.225 |
| Liver attenuation index, median (IQR) | 12 (7–16) | 12 (8–16) | 0.169 |
| Donation era | 0.001 | ||
| Early (n = 755) | 249 (33) | 506 (67) | |
| Late (n = 267) | 59 (22.1) | 208 (77.9) | |
| Graft type | 0.171 | ||
| Right lobe | 297 (30.6) | 674 (69.4) | |
| Left lobe | 11 (21.6) | 40 (78.4) | |
| MHV included in right lobe grafts (n = 971) | 0.379 | ||
| Complete/partial | 62 (28.2) | 158 (71.8) | |
| Not taken | 235 (31.3) | 516 (68.7) | |
| HBV-core-antibody positive | 0.231 | ||
| Yes | 51 (26.6) | 141 (73.4) | |
| No | 257 (31) | 573 (69) | |
| Future liver remnant, % | 0.043 | ||
| < 35 | 185 (32.7) | 380 (67.3) | |
| ≥ 35 | 123 (26.9) | 334 (73.1) | |
| Portal venous anatomy | 0.860 | ||
| Variant | 37 (30.8) | 83 (69.2) | |
| Standard | 271 (30) | 631 (70) | |
| Biliary anatomy | 0.040 | ||
| Variant | 69 (36.3) | 121 (63.7) | |
| Standard | 239 (28.7) | 593 (71.3) | |